Matti Jauhiainen (Finland)
Minerva Foundation Institute for Medical Research Cardiometabolic diseasesAuthor Of 3 Presentations
Introduction (ID 1499)
Conclusion (ID 1500)
O062 - Children with familial hypercholesterolemia display changes in LDL and HDL function: a cross-sectional study (ID 1406)
Abstract
Background and Aims
The functional status of lipoprotein particles contributes to atherogenesis. The tendency of plasma LDL particles to aggregate and the ability of HDL particles to induce and mediate reverse cholesterol transport associate with high and low risk for cardiovascular disease in adult patients, respectively. However, it is unknown whether children with familial hypercholesterolemia (FH) display lipoprotein function alterations.
We hypothesized that FH children had disrupted lipoprotein function.
Methods
We analyzed LDL aggregation susceptibility and HDL-apoA-I exchange to apoA-I ratio (HAE/apoA-I ratio), and activity of four proteins that regulate lipoprotein metabolism (CETP, LCAT, PLTP and PON1) in plasma samples derived from children with FH (n = 47) and from healthy children (n = 56). Potential biological mechanisms behind any variation in lipoprotein functionalities were explored using an NMR-based metabolomics profiling approach.
Results
LDL aggregation was higher and HAE/apoA-I ratio was lower in FH children than in healthy children. LDL aggregation associated positively with LDL-C and negatively with triglycerides, and HAE/apoA-I ratio associated negatively with LDL-C. Generally, the metabolomic profile for LDL aggregation was a mirror image of that for HAE/apoA-I ratio.
Conclusions
FH children displayed increased atherogenicity of LDL and disrupted HDL function. These newly observed functional alterations in LDL and HDL may help explain the risk for atherosclerotic cardiovascular disease in FH children.